DR. REEMA KUMARI - PowerPoint PPT Presentation

About This Presentation
Title:

DR. REEMA KUMARI

Description:

Associate professor Department of community medicine and public health 2) Prevention of secondary spread of pertussis by administering to: a) Symptomatic patients ... – PowerPoint PPT presentation

Number of Views:95
Avg rating:3.0/5.0
Slides: 37
Provided by: kgm5
Learn more at: http://www.kgmu.org
Category:
Tags: kumari | reema | culture | just

less

Transcript and Presenter's Notes

Title: DR. REEMA KUMARI


1
  • DR. REEMA KUMARI
  • Associate professor
  • Department of community medicine and public health

2
  • The earliest clear account of whooping cough was
    described in 1640 by Baillow, an epidemiologist
  • The name pertussis means violent cough, and
    was first used to describe the disease in 1679.
  • In China, the disease is known as Hundred Day
    Cough

3
  • An acute infectious disease, usually of young
    children caused by B.pertussis.
  • Insidious onset with mild fever and an irritating
    cough gradually becoming paroxyamal with the
    characteristic whoop

4
(No Transcript)
5
  • Pertussis toxin and filamentous hemagglutinin
    (FHA) allow binding of pertussis to repsiratory
    epithelial cells.
  • PT can then enter the bloodstream.

6
  • Pertussis is a disease of worldwide importance,
    with an estimated 285,000 deaths in 2001, with
    most occurring in Africa and SE Asia
  • According to the WHO,2010 there are 1.29 lac
    cases reported globally, with 95 occurring in
    developing countries,and the DPT(3) Immunisation
    rate was 85.
  • In India yr.1987 incidence was 1.63 lac cases,in
    2011only 39,091 cases were reported (decline of
    76)

7
(No Transcript)
8
  • AGENT FACTORS
  • B pertussis is very contagious, and attack rates
    among susceptible groups range from 50-100
    depending on the nature of the exposure.
  • B.pertusis occurs in smooth and rough phases,
    capsulated and non-capsulated form,elaborates an
    exotoxins and endotoxins
  • B.pertusis is antigenically highly complex.it
    carries 3 major agglutinogens-1,2,3 and several
    minor ones
  • Survives only for very short periods outside the
    human body

9
(No Transcript)
10
  • AGE disease of infants and pre-school children
    however, children under the age of 5 years are at
    the highest risk of developing more serious
    symptoms.
  • Being in close contact with an infected person
    for extended periods of time increases the risk
    of becoming infected
  • IMMUNITY recovery from whooping cough or
    adequate immunisation is followed by
    immunity.infants are susceptible to infection
    from birth bec. Maternal antibody does not appear
    to give them protection. no cross immunity with
    B. Parapertussis

11
  • B. pertusis infects only man, source is a case of
    pertusis
  • Transmission is felt to occur by aerosol droplet,
    and exposure to a coughing patient.
  • There are no known animal reservoirs for B
    pertussis, and the organism does not survive for
    prolonged periods in the environment.
  • No long-term carrier state had been identified,
    but asymptomatic culture positive persons can be
    detected during known exposures.

12
(No Transcript)
13
  • The bacilli occurs abundantly in the
    nasopharyngeal and bronchial secretions, which
    are infective
  • Objects freshly contaminated by such discharges
    are also infective

14
  • Whooping cough is most infectious during
    catarrhal stage.
  • The infective period may be considered to extend
    from a week after exposure to about 3 weeks after
    the onset of paroxysmal stage

15
  • Whole cell pertussis vaccine has been responsible
    for a major reduction in disease incidence, but
    has caused a shift in the peak age of disease.

16
  • Stage 1 (Catarrhal)
  • Cold, runny nose and irritating cough
  • Most infectious stage
  • Stage 2 (Paroxysmal)
  • Severe series of coughs usually ending with a
    high-pitched whoop
  • The whoop starts 1 to 2 weeks after the cold
    symptoms and lasts 1 to 2 months
  • Thick, clear, sticky mucous may be coughed up
    at the end of the coughing spasm
  • Coughing spasms are more frequent at night

17
  • Stage 3 (Convalescent)
  • Gradual disappearance of symptoms occurring
    over 2 to 4 weeks, however, coughing spells can
    last for weeks or months
  • Cough may become louder and may sound like it
    is getting worse as the person is getting better
  • Coughing may flare up again later in a cold or
    upper respiratory illness. This does not mean
    that the person has been re-infected with
    pertussis

18
  • After an incubation period of 1-3 weeks, signs
    and symptoms of the catarrhal phase begin
  • Symptoms include rhinorrhea, lacrimation,
    conjunctival injection, malaise, low grade fever,
    and are indistinguishable from those of many
    other URIs.
  • After a few days and up to a week of these
    symptoms, a dry nonproductive cough develops, and
    this evolves into a characteristic paroxysmal
    phase.

19
  • Patients are most contagious during the catarrhal
    phase and during the first two weeks after the
    onset of coughing.
  • Prodromal symptoms during this phase can include
    complaints of pharyngeal discomfort.
  • During this phase, patients can develop a marked
    leukocytosis, with WBC counts greater than
    50,000, with a relative lymphocytosis (less
    common in adults).

20
  • The cough paroxysm consists of a short series of
    expiratory bursts, followed by an inspiratory
    gasp, which results in the typical whoop.
  • The paroxysmal phase usually lasts 1-6 weeks, but
    can last up to 10 weeks
  • Not all children with pertussis exhibit the
    characteristic whoop, and it is fairly uncommon
    in infants, who may have apneic episodes

21
Child having Loud crowing inspiration
22
  • In adults, whooping is variable, ranging from
    20-40 in various studies. The disease is
    generally milder, but the paroxysmal cough may be
    just as prolonged.
  • Paroxysms can number more than 30 per 24 hours,
    and are more frequent at night, and can be
    stimulated by external stimuli, such as noises or
    cold air.

23
  • Classically they may end with a vomiting episode.
    They can be associated with sweating, flushing
    and syncope. Patients may cough up thick yellow
    plugs.
  • Pertussis is generally more severe in infants,
    but presentation can be more atypical in infants,
    as well as partially immunized children and
    previously immunized adolescents and adults.
  • In these groups the catarrhal phase can be
    shortened, and the true whooping phase may be
    absent.

24
  • The convalescent phase begins with a decrease in
    the intensity of the cough and paroxysms, but can
    still last for weeks.
  • It is not clear if pertussis can cause long term
    impairment of pulmonary function.

25
(No Transcript)
26
  • Complications occurs in 5-6 percent of cases
  • The chief complications of pertussis are
    bronchitis, bronchopneumonia and bronchiactasis
  • secondary infections- otitis media or pneumonia
    (either secondary to pertussis or other
    organisms)
  • Aspiration can occur secondary to the whooping
    and associated gasping

27
  • Patients can develop subconjunctival hemorrhages,
    epistaxis,haemoptysis and punctate cerebral
    haemorrhages which may cause convulsions and coma
  • CNS abnormalities can occur particularly in
    children 6 months and younger.

28
  • Direct fluorescent antibody tests (DFA) are often
    used as well, but they can be less sensitive and
    less specific, and may lead to overdiagnosis and
    overtreatment (higher false positives from cross
    reaction with normal naso-pharyngeal flora).
  • With new PCR technology becoming available, the
    ability to diagnose Bordetella infection has been
    greatly enhanced

29
  • A clinical case is defined as a cough illness
    lasting at least 2 weeks without other apparent
    cause accompanied by one of the following
  • Paroxysms of coughing
  • Inspiratory whoop
  • Posttussive vomiting

30
  • The newer macrolides (azithromycin and
    clarithromycin) have good in vitro acitivty
    against B pertussis, and Clarithromycin (500 mg
    bid) used for 10 14 days and Azithromycin (500
    mg/d) used for 5 7 days have been used with
    good results.

31
  • Steroids may reduce the number and severity of
    cough paroxysms, but are generally only
    recommended for infants with serious disease.

32
(No Transcript)
33
  • Antibiotics can be used for 2 purposes in the
    control and prevention of pertussis
  • 1) Treatment to modify clinical symptoms of
    pertussis by administering to symptomatic
    patients

34
  • 2) Prevention of secondary spread of pertussis by
    administering to
  • a) Symptomatic patients (treatment) and
    interrupting infectiousness and transmission by
    eliminating the organism from the respiratory
    system.
  • b) Asymptomatic contacts (prophylaxis) and
    interrupting transmission by eliminating any
    organisms that may have been contracted

35
  • Other methods of preventing the spread of
    Pertussis include
  • Washing hands with soap and warm water.
  • Teaching children to cover mouth and nose if
    coughing or sneezing and to wash hands after
    doing so.
  • Not sharing eating utensils and drinking
    glasses.
  • Minimizing the amount of contact you have with
    someone you know is infected or if you are
    infected, minimizing the amount of time you are
    around others.

36
THANK YOU
Write a Comment
User Comments (0)
About PowerShow.com